Management of Index Finger Metacarpophalangeal Joint Arthritis

Orthop Clin North Am. 2024 Oct;55(4):479-488. doi: 10.1016/j.ocl.2024.03.002. Epub 2024 May 28.

Abstract

Metacarpophalangeal joint arthritis of the index finger is a debilitating disease often caused by osteoarthritis or inflammatory arthritides such as rheumatoid arthritis. Treatment options include nonsurgical management with nonsteroidal anti-inflammatory drugs, splinting, occupational therapy, corticosteroid injections, and disease-modifying antirheumatic drugs. Operative management options include arthrodesis and arthroplasty, which can be further broken down into silicone implants and 2 component resurfacing implants. The article summarizes the current literature for each of the treatment options for metacarpophalangeal joint arthritis of the index finger.

Keywords: Arthrodesis; Arthroplasty; Index finger; MCP; Pyrocarbon; Silastic; Silicone.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Arthritis / etiology
  • Arthritis / therapy
  • Arthrodesis / methods
  • Humans
  • Metacarpophalangeal Joint* / surgery
  • Occupational Therapy / methods
  • Osteoarthritis / surgery
  • Osteoarthritis / therapy
  • Splints

Substances

  • Antirheumatic Agents
  • Anti-Inflammatory Agents, Non-Steroidal